Empowering scientists: delivering AI tools through an ELN framework at the enterprise level

17 January 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Artificial intelligence (AI) holds immense potential to revolutionize drug discovery, yet its widespread adoption within scientific enterprises faces significant hurdles. Key challenges include ensuring user-friendliness, managing complex workflows, and integrating diverse datasets. To address these issues, we propose a novel framework that leverages the familiar Electronic Lab Notebook (ELN) paradigm. By seamlessly integrating AI workflows as ELN protocols and AI job runs as ELN experiments, our approach provides a user-centric and scalable solution that aligns with established scientific practices. This ELN-based framework, implemented at Sygnature Discovery, adheres to FAIR principles, enhancing data findability, accessibility, interoperability, and reusability. By mirroring the intuitive ELN interface, our solution empowers bench scientists to easily access and utilize cutting-edge AI tools, accelerating drug discovery efforts and maximizing the return on AI investments.

Keywords

Drug discovery
Artificial intelligence
Electronic lab notebook

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.